Dr. Bruce Mazer explains the LEAP study

Bruce MazerDr. Bruce Mazer explains how the Learning Early about Peanut Allergy (LEAP) trial is changing our approach to peanut allergy.

The study found that infants (between 4−11 months) who consumed at least 6 grams of peanut per week were significantly less likely to develop an allergy by 5 years of age, compared to infants who avoided peanut entirely.

CTV news interview
National Post opinion editorial
Montreal Gazette opinion editorial

Dr. Mazer is division head of Allergy and Immunology at the Montreal Children’s Hospital and an AllerGen investigator who is leading a study to develop an effective and safe treatment of cow’s milk allergy with oral immunotherapy (OIT).

Posted in Investigator news, Media coverage

Archives